126 related articles for article (PubMed ID: 24472318)
1. Transcription factor C/EBP-β mediates downregulation of dipeptidyl-peptidase III expression by interleukin-6 in human glioblastoma cells.
Singh R; Sharma MC; Sarkar C; Singh M; Chauhan SS
FEBS J; 2014 Mar; 281(6):1629-41. PubMed ID: 24472318
[TBL] [Abstract][Full Text] [Related]
2. Ets-1/Elk-1 is a critical mediator of dipeptidyl-peptidase III transcription in human glioblastoma cells.
Shukla AA; Jain M; Chauhan SS
FEBS J; 2010 Apr; 277(8):1861-75. PubMed ID: 20236318
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of CCAAT/enhancer binding protein beta correlates with prognosis in glioma patients.
Homma J; Yamanaka R; Yajima N; Tsuchiya N; Genkai N; Sano M; Tanaka R
Oncol Rep; 2006 Mar; 15(3):595-601. PubMed ID: 16465418
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-1 beta induction of matrix metalloproteinase-1 transcription in chondrocytes requires ERK-dependent activation of CCAAT enhancer-binding protein-beta.
Raymond L; Eck S; Mollmark J; Hays E; Tomek I; Kantor S; Elliott S; Vincenti M
J Cell Physiol; 2006 Jun; 207(3):683-8. PubMed ID: 16453302
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia down-regulates CCAAT/enhancer binding protein-alpha expression in breast cancer cells.
Seifeddine R; Dreiem A; Blanc E; Fulchignoni-Lataud MC; Le Frère Belda MA; Lecuru F; Mayi TH; Mazure N; Favaudon V; Massaad C; Barouki R; Massaad-Massade L
Cancer Res; 2008 Apr; 68(7):2158-65. PubMed ID: 18381421
[TBL] [Abstract][Full Text] [Related]
6. Co-operative functions between nuclear factors NFkappaB and CCAT/enhancer-binding protein-beta (C/EBP-beta) regulate the IL-6 promoter in autocrine human prostate cancer cells.
Xiao W; Hodge DR; Wang L; Yang X; Zhang X; Farrar WL
Prostate; 2004 Dec; 61(4):354-70. PubMed ID: 15389813
[TBL] [Abstract][Full Text] [Related]
7. Differential regulation of elafin in normal and tumor-derived mammary epithelial cells is mediated by CCAAT/enhancer binding protein beta.
Yokota T; Bui T; Liu Y; Yi M; Hunt KK; Keyomarsi K
Cancer Res; 2007 Dec; 67(23):11272-83. PubMed ID: 18056453
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-6 and mevastatin regulate plasminogen activator inhibitor-1 through CCAAT/enhancer-binding protein-delta.
Dong J; Fujii S; Li H; Nakabayashi H; Sakai M; Nishi S; Goto D; Furumoto T; Imagawa S; Zaman TA; Kitabatake A
Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1078-84. PubMed ID: 15718495
[TBL] [Abstract][Full Text] [Related]
9. Expression of dipeptidyl peptidase-IV activity and/or structure homologs in human meningiomas.
Stremenová J; Mares V; Lisá V; Hilser M; Krepela E; Vanicková Z; Syrucek M; Soula O; Sedo A
Int J Oncol; 2010 Feb; 36(2):351-8. PubMed ID: 20043068
[TBL] [Abstract][Full Text] [Related]
10. Lingual antimicrobial peptide and IL-8 expression are oppositely regulated by the antagonistic effects of NF-κB p65 and C/EBPβ in mammary epithelial cells.
Liu S; Shi X; Bauer I; Günther J; Seyfert HM
Mol Immunol; 2011 Mar; 48(6-7):895-908. PubMed ID: 21255844
[TBL] [Abstract][Full Text] [Related]
11. Autoregulation enables different pathways to control CCAAT/enhancer binding protein beta (C/EBP beta) transcription.
Niehof M; Kubicka S; Zender L; Manns MP; Trautwein C
J Mol Biol; 2001 Jun; 309(4):855-68. PubMed ID: 11399064
[TBL] [Abstract][Full Text] [Related]
12. Regulation of Bcl-2 expression by C/EBP in t(14;18) lymphoma cells.
Heckman CA; Wheeler MA; Boxer LM
Oncogene; 2003 Sep; 22(39):7891-9. PubMed ID: 12970736
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-8 overexpression in astrocytomas is induced by prostaglandin E2 and is associated with the transcription factors CCAAT/enhancer-binding protein-β and CCAAT/enhancer-binding homologous protein.
Venza M; Visalli M; Alafaci C; Caffo M; Caruso G; Salpietro FM; Tomasello F; Teti D
Neurosurgery; 2011 Sep; 69(3):713-21; discussion 721. PubMed ID: 21471847
[TBL] [Abstract][Full Text] [Related]
14. C/EBPβ promotes angiogenesis through secretion of IL-6, which is inhibited by genistein, in EGFRvIII-positive glioblastoma.
Liu X; Liu K; Qin J; Hao L; Li X; Liu Y; Zhang X; Liu X; Li P; Han S; Mao Z; Shen L
Int J Cancer; 2015 Jun; 136(11):2524-34. PubMed ID: 25382637
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of human hepatic flavin containing monooxygenase 3 (FMO3) by CCAAT/enhancer-binding protein beta (C/EBPbeta) liver inhibitory and liver activating proteins.
Klick DE; Shadley JD; Hines RN
Biochem Pharmacol; 2008 Jul; 76(2):268-78. PubMed ID: 18555208
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms underlying differential expression of interleukin-8 in breast cancer cells.
Freund A; Jolivel V; Durand S; Kersual N; Chalbos D; Chavey C; Vignon F; Lazennec G
Oncogene; 2004 Aug; 23(36):6105-14. PubMed ID: 15208657
[TBL] [Abstract][Full Text] [Related]
17. C/EBPzeta (CHOP/Gadd153) is a negative regulator of LPS-induced IL-6 expression in B cells.
Gao H; Schwartz RC
Mol Immunol; 2009 Dec; 47(2-3):390-7. PubMed ID: 19782405
[TBL] [Abstract][Full Text] [Related]
18. A composite C/EBP binding site is essential for the activity of the promoter of the IL-3/IL-5/granulocyte-macrophage colony-stimulating factor receptor beta c gene.
van Dijk TB; Baltus B; Raaijmakers JA; Lammers JW; Koenderman L; de Groot RP
J Immunol; 1999 Sep; 163(5):2674-80. PubMed ID: 10453008
[TBL] [Abstract][Full Text] [Related]
19. Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein beta.
Zhou J; Gurates B; Yang S; Sebastian S; Bulun SE
Cancer Res; 2001 Mar; 61(5):2328-34. PubMed ID: 11280806
[TBL] [Abstract][Full Text] [Related]
20. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
Zerbini LF; Wang Y; Cho JY; Libermann TA
Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
